Outlook Therapeutics (OTLK) Common Equity (2015 - 2026)
Outlook Therapeutics (OTLK) posted Common Equity of -$10.39 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$37.19 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Common Equity came in at -$32.19 million.
- In prior fiscal years, Outlook Therapeutics' Common Equity was -$73.08 million in FY2024, -$14.44 million in FY2023, $8.74 million in FY2022 (+89.6%) and $4.61 million in FY2021 (+63.0%).
- The fiscal Q3 2026 figure stands as the highest quarterly Common Equity since fiscal Q3 2023.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was -$28.99 million (Q2 2026), -$38.55 million (Q1 2026) and -$32.19 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | -10.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.39 Mn |
| Mar 31, 2026 | -28.99 Mn |
| Dec 31, 2025 | -38.55 Mn |
| Sep 30, 2025 | -32.19 Mn |
| Jun 30, 2025 | -37.19 Mn |
| Mar 31, 2025 | -32.46 Mn |
| Dec 31, 2024 | -50.29 Mn |
| Sep 30, 2024 | -73.08 Mn |
| Jun 30, 2024 | -83.67 Mn |
| Mar 31, 2024 | -134.24 Mn |
| Dec 31, 2023 | -24.34 Mn |
| Sep 30, 2023 | -14.44 Mn |
| Jun 30, 2023 | -5.50 Mn |
| Mar 31, 2023 | 10.49 Mn |
| Dec 31, 2022 | 15.76 Mn |
| Sep 30, 2022 | 8.74 Mn |
| Jun 30, 2022 | 20.08 Mn |
| Mar 31, 2022 | 35.96 Mn |
| Dec 31, 2021 | 48.82 Mn |
| Sep 30, 2021 | 4.61 Mn |
API Access
Outlook Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();